Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013774
Filing Date
2020-11-13
Accepted
2020-11-13 06:45:47
Documents
53
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20200930x10q.htm 10-Q 1831097
2 EX-10.3 mist-20200930ex103b7163f.htm EX-10.3 16091
3 EX-31.1 mist-20200930ex3114775f2.htm EX-31.1 11784
4 EX-31.2 mist-20200930ex312d81973.htm EX-31.2 11794
5 EX-32.1 mist-20200930ex3214a2f35.htm EX-32.1 9444
  Complete submission text file 0001558370-20-013774.txt   5683017

Data Files

Seq Description Document Type Size
6 EX-101.INS mist-20200930.xml EX-101.INS 1171675
7 EX-101.SCH mist-20200930.xsd EX-101.SCH 34566
8 EX-101.CAL mist-20200930_cal.xml EX-101.CAL 34381
9 EX-101.DEF mist-20200930_def.xml EX-101.DEF 127044
10 EX-101.LAB mist-20200930_lab.xml EX-101.LAB 317287
11 EX-101.PRE mist-20200930_pre.xml EX-101.PRE 248758
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 201309115
SIC: 2834 Pharmaceutical Preparations